DECHRA FINANCE LIMITED

Company number 09129928

Date	Type	Description	View / Download
25 Jan 2024	AA	Full accounts made up to 30 June 2023	(19 pages)
27 Nov 2023	TM01	Termination of appointment of Anthony Gerard Griffin as a director on 27 November 2023	(1 page)
14 Jul 2023	CS01	Confirmation statement made on 14 July 2023 with updates	(4 pages)
22 Feb 2023	SH19	Statement of capital on 22 February 2023 EUR 1	(5 pages)
22 Feb 2023	SH20	Statement by Directors	(1 page)
22 Feb 2023	CAP-SS	Solvency Statement dated 22/02/23	(1 page)
22 Feb 2023	RESOLUTIONS	Resolutions RES06 ‐ Resolution of reduction in issued share capital	(1 page)
21 Feb 2023	RP04CS01	Second filing of Confirmation Statement dated 14 July 2022	(3 pages)
13 Feb 2023	SH19	Statement of capital on 13 February 2023 EUR 18,265,546 ANNOTATION Clarification this form is a second filing of the SH19 registered on 20/05/2022.	(3 pages)
09 Dec 2022	AA	Full accounts made up to 30 June 2022	(18 pages)
14 Jul 2022	CS01	Confirmation statement made on 14 July 2022 with updates ANNOTATION Clarification a second filed CS01 (Statement of Capital, Shareholder information) was registered on 21/02/2023	(6 pages)
20 May 2022	SH19	Statement of capital on 20 May 2022 EUR 1 ANNOTATION Clarification a second filed SH19 was registered on 13/02/2023.	(6 pages)
20 May 2022	SH20	Statement by Directors	(1 page)
20 May 2022	CAP-SS	Solvency Statement dated 17/05/22	(1 page)
20 May 2022	RESOLUTIONS	Resolutions RES06 ‐ Resolution of reduction in issued share capital	(1 page)
24 Nov 2021	AA	Full accounts made up to 30 June 2021	(18 pages)
14 Jul 2021	CS01	Confirmation statement made on 14 July 2021 with updates	(4 pages)
05 May 2021	CH01	Director's details changed for Mr Anthony Gerard Griffin on 28 April 2021	(2 pages)
19 Jan 2021	AA	Full accounts made up to 30 June 2020	(16 pages)
24 Dec 2020	RESOLUTIONS	Resolutions RES14 ‐ £18,265,544 capitalised 03/12/2020 RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES13 ‐ All matters transacted by company in respect of allotment of shares and of bonus issue approved; dechra pharmaceuticals PLC waives any right to receive bonus issue shares 03/12/2020	(3 pages)
14 Dec 2020	SH01	Statement of capital following an allotment of shares on 3 December 2020 EUR 130,468,182	(3 pages)
14 Jul 2020	CS01	Confirmation statement made on 14 July 2020 with no updates	(3 pages)
07 Jan 2020	AA	Full accounts made up to 30 June 2019	(18 pages)
06 Dec 2019	AP01	Appointment of Mr Paul Nicholas Sandland as a director on 5 December 2019	(2 pages)
15 Jul 2019	CS01	Confirmation statement made on 14 July 2019 with no updates	(3 pages)